Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced the clearance, by the U.S. Food and...
New England Biolabs, announced the launch of the NEBNext Enzymatic 5hmC-seq Kit a novel enzyme-based method for the specific detection of 5hmC sites. The gentle,...
AbbVie, announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition, ImmunoGen is now part of AbbVie.
"Together with ImmunoGen,...
Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or...
CooperSurgical, a global leader in fertility and women's health, and Fulgent Genetics, Inc. , a technology-based company with a well-established clinical diagnostic business and...
